MoneyWorks4Me

Hester Biosciences - Quaterly Results

31 Jan 2023 Evaluate
The sales moved up 31.06% to Rs. 707.73 millions for the December 2022 quarter as compared to Rs. 540.01 millions during the year-ago period.Profit for the quarter ended December 2022 increased merely by1.62% to Rs. 107.29  millions from Rs. 105.58 millions.Operating profit for the quarter ended December 2022 rose to 199.49 millions as compared to 164.53 millions of corresponding quarter ended December 2021.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202212 202112 % Var 202212 202112 % Var 202203 202103 % Var
Sales 707.73 540.01 31.06 1933.04 1691.00 14.31 2193.51 2084.77 5.22
Other Income 9.62 12.22 -21.28 43.73 35.76 22.29 46.57 16.48 182.58
PBIDT 199.49 164.53 21.25 483.40 540.91 -10.63 652.26 736.41 -11.43
Interest 31.37 3.65 759.45 61.49 10.85 466.73 24.68 39.47 -37.47
PBDT 168.12 160.88 4.50 421.91 530.06 -20.40 627.58 644.16 -2.57
Depreciation 24.37 23.34 4.41 71.67 69.54 3.06 95.02 96.33 -1.36
PBT 143.75 137.54 4.52 350.24 460.52 -23.95 532.56 547.83 -2.79
TAX 36.46 31.96 14.08 89.45 114.83 -22.10 137.39 148.82 -7.68
Deferred Tax 7.50 -3.37 -322.55 5.08 -8.06 -163.03 -5.14 -14.83 -65.34
PAT 107.29 105.58 1.62 260.79 345.69 -24.56 395.17 399.01 -0.96
Equity 85.07 85.07 0.00 85.07 85.07 0.00 85.07 85.07 0.00
PBIDTM(%) 28.19 30.47 -7.49 25.01 31.99 -21.82 29.74 35.32 -15.82
Peers
Company Name CMP
Sun Pharma. Inds. 1864.50
Dr. Reddys Labs. 1215.70
Cipla 1378.40
Lupin 2096.00
Zydus Lifesciences 1166.50
View more..